Glycosmicine,
604-50-2,
1-methylquinazoline-2,4(1H,3H)-dione,
1-Methyl-2,4(1H,3H)-quinazolinedione,
2,4(1H,3H)-QUINAZOLINEDIONE, 1-METHYL-,
1-methylquinazoline-2,4-dione,
NSC 401254,
Methyl-1 (1H,3H)quinazolinedione-2,4,
RWFOOMQYIRITHL-UHFFFAOYSA-N,
Methyl-1 (1H,3H)quinazolinedione-2,4 [French],
2,4(1H,3H)-Quinazolinedione,1-methyl-,
1,2,3,4-tetrahydro-1-methyl-2,4-dioxoquinazoline,
1-methyl-1,3-dihydroquinazoline-2,4-dione,
NSC401254,
AC1L1Y4U,
SCHEMBL5033267,
CTK5B1502,
DTXSID20209154,
1-Methyl-2,3H)-Quinazolinedione,
ZINC175955,
ALBB-019518,
2,3H)-Quinazolinedione, 1-methyl-,
6531AE,
MFCD00731030,
SBB072489,
AKOS000266261,
DS-4731,
MCULE-9249167908,
NSC-401254,
AJ-17621,
AK125139,
ST095770,
DB-072797,
LS-140152,
FT-0746015,
A18968,
W-7531,
AG-690/33347036,
SR-01000467676,
1-methyl-1,2,3,4-tetrahydroquinazoline-2,4-dione,
SR-01000467676-1,
1-Methyl quinazolinine dione,
C9H8N2O2,
C9-H8-N2-O2,
CID11788,